Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Learn ways to combine income boosting with debt payoff strategies. Enhance your financial wellness effectively.
28,655 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A New Mexico verdict against Meta and a California ruling involving Meta and YouTube mark a turning point in lawsuits...
Investors are watching IonQ as it edges toward scalable quantum systems through a photonic interconnect. This breakth...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...
A five-year restraining order against a persistent admirer shows how safety, law, and money intersect. Learn practica...
Investors weigh AI infrastructure costs against Azure growth as Microsoft and tech peers face margin pressure. Here’s...
Tech stocks regain momentum as data-center spending reshapes the market. Oracle stands out as a potential upside surp...
Two software giants sit at the crossroads of business efficiency and security. This guide breaks down Salesforce and ...
SBI Holdings is issuing a ¥10 billion three-year retail bond with an XRP perk tied to SBI VC Trade accounts, aiming t...
When a company's CEO sells 31,000 shares worth roughly $1.41 million, it sparks questions for investors. This guide e...
A legendary TV send-off isn’t just about drama. It exposes the hidden costs of chaos—how budgets, insurance, and risk...